Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process.
D014150:Antipsychotic Agents / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism / Q000502:physiology*; D005475:Flupenthixol / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007536:Isomerism; D011954:Receptors, Dopamine / Q000378:metabolism; D012559:Schizophrenia / Q000378:metabolism / Q000503:physiopathology*
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D005475:Flupenthixol; D004298:Dopamine